Cite

HARVARD Citation

    Dignass, A. et al. (2014). Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial. Journal of Crohn's and colitis. pp. 970-980. [Online]. 
  
Back to record